Atlas Trials

D9319C00001- 1L OC Mono Global RCT

Clinical trial NCT04884360 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04884360
Sponsor
AstraZeneca
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2021-05-31
Primary completion
2026-07-27
Enrollment
366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.